XJPX
4203
Market cap5.13bUSD
Oct 09, Last price
9,320.00JPY
1D
0.90%
1Q
29.44%
Jan 2017
469.16%
Name
Sumitomo Bakelite Co Ltd
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Sumitomo Bakelite Company Limited, established in 1932 and headquartered in Tokyo, Japan, operates worldwide alongside its subsidiaries. The company is engaged in the research, development, manufacturing, and global distribution of a diverse product portfolio encompassing semiconductor materials, plastic items, and life-related solutions. For the semiconductor industry, their specialized materials include epoxy resin molding compounds for device encapsulation, liquid photosensitive coating resins, advanced liquid resins for semiconductor applications, and crucial substrate materials for semiconductor packages. Beyond electronics, Sumitomo Bakelite produces a wide array of advanced plastic and industrial materials. This range features phenolic molding compounds, various phenolic resins, custom molded parts, and synthetic resin adhesives. They also manufacture copper-clad laminates (both phenolic and epoxy resin types) and components for aircraft interiors. Their broader plastics offerings feature melamine resin decorative laminates and sheets, versatile vinyl resin sheets and multilayer options, films designed for freshness preservation, and plates made from polycarbonate and PVC resins. Within the life sciences and healthcare sectors, the company provides medical devices, pharmaceuticals, and various biotechnology-related products. Additionally, they offer design and contracting services for waterproofing projects and contribute to interior decoration solutions for commercial spaces. Sumitomo Bakelite's comprehensive product lineup supports a broad spectrum of industries, including automotive, railway, and aviation; electrical and electronic equipment manufacturing; construction and residential development; various industrial applications; medical and laboratory institutions; biotechnology; agriculture; and specialized functional packaging, as well as retail store interiors.
Key people
Shinchi Kajiya
President, Executive President, Representative Director · since 2025
Sumitoshi Asakuma
Executive Vice President · since 2024
Masayuki Inagaki
Executive Vice President, Representative Director · since 2022
Takashi Kobayashi
Senior Managing Executive Officer, Director · since 2023
Toshiya Hirai
Managing Executive Officer, Director · since 2023
Takeshi Saino
Managing Executive Officer · since 2025
Nobuyuki Sashida
Managing Executive Officer · since 2022
Makoto Suzuki
Managing Executive Officer · since 2024
Yasuhisa Ikeyama
Executive Officer, Chief Director of Human Resources · since 2024
Toshihide Kanazawa
Executive Officer, Chief Director of Materials Solutions Sales · since 2024
Takeshi Mori
Executive Officer · since 2023
Hisao Nakanishi
Executive Officer, Chief Director of Research and Development · since 2021
Hiroshi Nomura
Executive Officer · since 2023
Hiromi Oki
Executive Officer, Director of Sustainability Promotion, Manager of Corporate Strategy Planning · since 2024
Akiko Okubo
Executive Officer, Chief Director of Medical Device Business, Manager of Kobe Office · since 2024
Atsushi Tanaka
Executive Officer, Chief Director of Film & Sheet Sales · since 2021
Kazuhiko Fujiwara
Chairman of the Board, Representative Director · since 2025
Keisuke Kurachi
Senior Managing Executive Officer, Director · since 2023
Kazuo Matsuda
Independent Director · since 2016
Independent Director · since 2021
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||